Publications

Export 14 results:
Auteur Title Type [ Année(Asc)]
Filtres: Auteur is Foster, Jane A  [Enlever les filtres]
2021
Yrondi A, Fiori LM, Nogovitsyn N, Hassel S, Théroux JFrançois, Aouabed Z, Frey BN, Lam RW, Milev R, Müller DJ et al..  2021.  Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report.. Transl Psychiatry. 11(1):469.
Marshe VS, Maciukiewicz M, Hauschild A-C, Islam F, Qin L, Tiwari AK, Sibille E, Blumberger DM, Karp JF, Flint AJ et al..  2021.  Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response.. Transl Psychiatry. 11(1):127.
Suh JSu, Fiori LM, Ali M, Harkness KL, Ramonas M, Minuzzi L, Hassel S, Strother SC, Zamyadi M, Arnott SR et al..  2021.  Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report.. Psychoneuroendocrinology. 132:105348.
Caspani G, Turecki G, Lam RW, Milev RV, Frey BN, Macqueen GM, Müller DJ, Rotzinger S, Kennedy SH, Foster JA et al..  2021.  Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report.. Commun Biol. 4(1):903.
Saeedi S, Nagy C, Ibrahim P, Théroux J-F, Wakid M, Fiori LM, Yang J, Rotzinger S, Foster JA, Mechawar N et al..  2021.  Neuron-derived extracellular vesicles enriched from plasma show altered size and miRNA cargo as a function of antidepressant drug response.. Mol Psychiatry.
Fiori LM, Orri M, Aouabed Z, Théroux JFrançois, Lin R, Nagy C, Frey BN, Lam RW, Macqueen GM, Milev R et al..  2021.  Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response.. Transl Psychiatry. 11(1):439.
2020
Belzeaux R, Gorgievski V, Fiori LM, Lopez JPablo, Grenier J, Lin R, Nagy C, Ibrahim EChérif, Gascon E, Courtet P et al..  2020.  GPR56/ADGRG1 is associated with response to antidepressant treatment.. Nat Commun. 11(1):1635.
Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R et al..  2020.  A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.. BMC Psychiatry. 20(1):268.
Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G et al..  2020.  Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.. J Clin Psychiatry. 81(4)
2019
Yrondi A, Fiori LM, Frey BN, Lam RW, Macqueen GM, Milev R, Müller DJ, Foster JA, Kennedy SH, Turecki G.  2019.  Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN-BIND-1 report.. Int J Neuropsychopharmacol.
Ju C, Fiori LM, Belzeaux R, Théroux J-F, Chen GGang, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P et al..  2019.  Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.. Transl Psychiatry. 9(1):254.
Belzeaux R, Fiori LM, Lopez JPablo, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW et al..  2019.  Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment.. J Clin Psychiatry. 80(3)
2017
Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, McAndrews MPat, Blier P, Evans K, Foster JA, Frey BN et al..  2017.  The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.. J Affect Disord. 227:542-549.
2016
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.